Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

EMERGING MARKETS-Indonesia shares pare gains on disappointing GDP data; Indian c.bank holds rate

Published 02/05/2021, 01:03 PM
Updated 02/05/2021, 01:10 PM
© Reuters.

* Graphic: World FX rates https://tmsnrt.rs/2RBWI5E
* Indonesia's Q4 GDP shrinks more than expected
* Indian c.bank holds rates
* Most currencies weaker as USD heads for best week in 3
months

By Shruti Sonal
Feb 5 (Reuters) - Indonesian shares erased some early gains
on Friday after the economy shrank slightly more than expected
in the fourth quarter, while the Indian rupee strengthened
against the dollar after the central bank kept rates on hold.
The Jakarta benchmark .JKSE , which had added as much as
0.7% in early trade, retraced to be up only 0.1% by 0407 GMT.
Gross domestic product in Southeast Asia's largest economy
fell slightly more than expected in the fourth quarter, leading
to its first full-year contraction in over two decades as it
struggled with the fallout of the COVID-19 pandemic.
ING analysts expect Indonesia's GDP to continue to contract
in the first quarter of 2021 and see the Bank Indonesia keeping
the door open for further easing, with recent weakness in rupiah
IDR= the main impediment to further rate cuts.
In India, the rupee INR=IN slightly strengthened after the
central bank held its key rates steady in a widely expected move
and reiterated its support for economic recovery by ensuring
ample rupee liquidity in the banking system. Shares .NSEI retreated slightly from all-time highs after
the announcement and were trading up 0.4% up.
Measures to cap rising bond yields in the wake of a
higher-than-expected fiscal deficit announced earlier in the
week are likely to be "critical watchpoints", said Lakshmi Iyer,
Chief Investment Officer of Debt and Head of Products at Kotak
Mahindra Asset Management.
Thai .SETI and Philippine .PSI benchmarks edged 0.7%
higher each, in line with gains in broader markets following a
strong finish on Wall Street overnight as progress in vaccine
distribution prompted bets on further normalisation in the
global economic recovery.
Thai shares were on track to post a 2% weekly gain, after
three consecutive weeks in the red.
The country's health minister said on Thursday that the
tourism-reliant country will import the first doses of
AstraZeneca (NASDAQ:AZN)'s vaccine from Asia after Europe enforced export
controls. In the Philippines, annual inflation accelerated faster than
expected to hit the highest level in two years in January,
limiting the central bank's room for further interest rate cuts
at its meeting next week. Most currencies in the region weakened as the dollar headed
for its best weekly gain in three months, supported by growing
confidence that the U.S. economic recovery will outpace global
peers. The Indonesian rupiah IDR= , Malaysian ringgit MYR= ,
Singapore dollar SGD= and the Thai baht THB=TH fell between
0.1% and 0.4%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Highlights:

** Thai Bev to sell 20% of beer business in blockbuster
Singapore IPO ** In the Philippines, top index gainers are LT Group Inc
LTG.PS , GT Capital Holdings Inc GTCAP.PS , Jollibee Foods
Corp JFC.PS
** Singapore's 10-year benchmark yield is down 2 basis
points at 1.066%

Asia stock indexes and
currencies at 0455 GMT
COUNTRY FX RIC FX FX INDE STOCKS STOCK
DAILY YTD % X DAILY S YTD
% % %
Japan JPY= -0.01 -2.19 <.N2 1.33 4.64
25>
China

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.